HCP1803
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for HCP1803, covering 2022-07-14 to 2025-02-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients with Essential Hypertension [Phase 3]